FATE Fate Therapeutics, Inc.
Healthcare$2.15-4.44%ClosedMarket Cap: $250.6M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$4.00
Target (Median)
$4.00
Target Range
$4.00 - $4.00
Upside from current price: 86.0%
Rating Distribution
1 Strong Buy5 Buy6 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-04 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-31 | HC Wainwright & Co. | upgrade | Buy | Neutral |
| 2025-10-27 | Wedbush | upgrade | Outperform | Neutral |
| 2025-10-27 | Needham | maintain | Hold | Hold |
| 2025-08-13 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2025-06-12 | Needham | maintain | Hold | Hold |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.97 | $5.3M | 8 |
| Sun Dec 31 | $-0.99 | $5.2M | 5 |
| Mon Dec 31 | $-0.91 | $60.2M | 1 |
| Tue Dec 31 | $-0.65 | $156.4M | 1 |